The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
0.460
+0.019 (4.19%)
At close: Jul 2, 2024, 4:00 PM
0.450
-0.010 (-2.15%)
After-hours: Jul 2, 2024, 7:26 PM EDT

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2023202220212020
Market Capitalization
34150119714311
Market Cap Growth
132.33%26.04%-83.29%130.01%-
Enterprise Value
88187154599316
PE Ratio
--2.221755.35-67.20-21.68
PS Ratio
0.100.460.473.521.66
PB Ratio
0.832.640.976.8611.05
P/FCF Ratio
-2.93-3.68-1.77-20.10-452.62
P/OCF Ratio
-3.20-4.14-1.93-21.85611.22
EV/Sales Ratio
0.260.580.612.951.69
EV/EBITDA Ratio
-3.76-3.3918.48-78.45-28.03
EV/EBIT Ratio
-3.31-3.0639.35-54.58-21.87
EV/FCF Ratio
-4.28-4.58-2.28-16.87-461.27
Debt / Equity Ratio
2.902.100.880.000.42
Debt / EBITDA Ratio
-2.63-2.1713.01-0.02-1.06
Debt / FCF Ratio
-2.99-2.93-1.61-0.01-17.39
Quick Ratio
2.733.623.844.580.81
Current Ratio
3.094.134.395.171.04
Asset Turnover
1.591.451.071.510.99
Interest Coverage
-8.46-9.020.96-34.31-41.69
Return on Equity (ROE)
-90.70%-87.00%0.10%-16.10%-132.90%
Return on Assets (ROA)
-26.80%-30.40%0.00%-7.90%-7.50%
Return on Capital (ROIC)
-38.55%-43.59%-35.42%-43.95%-20.48%
Earnings Yield
-168.71%-45.12%0.06%-1.49%-4.61%
FCF Yield
-117.06%-27.17%-56.37%-4.97%-0.22%
Buyback Yield / Dilution
-1.07%8.51%-21.70%-12.03%-491.18%
Total Shareholder Return
-1.07%8.51%-21.70%-12.03%-491.18%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).